- Home
- ORIC vs PMT Comparison
ORIC vs PMT Comparison
Compare ORIC & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- PMT
- Stock Information
- Founded
- ORIC 2014
- PMT 2009
- Country
- ORIC United States
- PMT United States
- Employees
- ORIC N/A
- PMT N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- PMT Real Estate Investment Trusts
- Sector
- ORIC Health Care
- PMT Real Estate
- Exchange
- ORIC Nasdaq
- PMT Nasdaq
- Market Cap
- ORIC 1.1B
- PMT 1.1B
- IPO Year
- ORIC 2020
- PMT 2009
- Fundamental
- Price
- ORIC $12.96
- PMT $12.20
- Analyst Decision
- ORIC Strong Buy
- PMT Hold
- Analyst Count
- ORIC 8
- PMT 5
- Target Price
- ORIC $16.57
- PMT $14.13
- AVG Volume (30 Days)
- ORIC 1.5M
- PMT 1.0M
- Earning Date
- ORIC 11-06-2025
- PMT 10-21-2025
- Dividend Yield
- ORIC N/A
- PMT 12.99%
- EPS Growth
- ORIC N/A
- PMT N/A
- EPS
- ORIC N/A
- PMT 0.91
- Revenue
- ORIC N/A
- PMT $564,655,000.00
- Revenue This Year
- ORIC N/A
- PMT N/A
- Revenue Next Year
- ORIC N/A
- PMT $27.87
- P/E Ratio
- ORIC N/A
- PMT $13.54
- Revenue Growth
- ORIC N/A
- PMT N/A
- 52 Week Low
- ORIC $3.90
- PMT $11.60
- 52 Week High
- ORIC $14.93
- PMT $14.93
- Technical
- Relative Strength Index (RSI)
- ORIC 53.61
- PMT 48.77
- Support Level
- ORIC $11.71
- PMT $12.44
- Resistance Level
- ORIC $13.80
- PMT $12.76
- Average True Range (ATR)
- ORIC 0.69
- PMT 0.25
- MACD
- ORIC -0.11
- PMT 0.04
- Stochastic Oscillator
- ORIC 50.63
- PMT 51.93
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.